Clinical Trial Update: Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating orally administered moxidectin for Onchocerciasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onchocerciasis

Drugs mentioned

• Moxidectin (moxidectin)

Snippet

Sponsor: Medicines Development for Global Health | Conditions: Onchocerciasis | Phase 2 | Status: COMPLETED